HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemophilus influenzae in hospitalized adults: current perspectives.

Abstract
In an eight year period 16 cases of serious extrapulmonary Hemophilus influenzae infection in adults were identified, including cases of meningitis, pericarditis, epiglottitis, empyema, cellulitis, osteomyelitis, endometritis, urinary tract infection, orbital cellulitis, primary peritonitis, mesenteric lymphadenitis and aortic graft infection. An 18 month prospective study of H. influenzae infection in hospitalized adults identified 10 cases of bronchitis, 25 of pneumonia and 65 of respiratory tract colonization, but there were no extrapulmonary infections. In 29 percent of the respiratory tract infections, H. influenzae appeared to be a nosocomial pathogen; in 71 percent, the infection was mixed. Finally, 110 clinical isolates of H. influenzae were studied for antimicrobial susceptibility. Eight percent were ampicillin resistant, two strains were resistant to tetracycline and one to chloramphenicol, but all were susceptible to trimethoprim-sulfamethoxazole and cefamandole.
AuthorsH B Simon, F S Southwick, R C Moellering Jr, E Sherman
JournalThe American journal of medicine (Am J Med) Vol. 69 Issue 2 Pg. 219-26 (Aug 1980) ISSN: 0002-9343 [Print] United States
PMID6967696 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Cefamandole
  • Trimethoprim
  • Sulfamethoxazole
Topics
  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents (pharmacology)
  • Cefamandole (pharmacology)
  • Cross Infection (etiology)
  • Drug Resistance, Microbial
  • Female
  • Haemophilus Infections (diagnosis)
  • Haemophilus influenzae (drug effects, isolation & purification)
  • Hospitalization
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Respiratory Tract Infections (etiology)
  • Sulfamethoxazole (pharmacology)
  • Trimethoprim (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: